Skip to content

Heparin Effect on Diabetic Foot Ulcer

Therapeutic Effects of Heparin on Treatment of chronic diabetic foot ulcers: a randomized blind controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016120130508N2
Enrollment
136
Registered
2017-04-05
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diabetic Foot Ulcer. Insulin-dependent diabetes mellitus with other specified complications

Interventions

Intervention 1: Study group: Daily injection of 40 mg of low-molecular weight heparin during 30 days. Intervention 2: Control group: Daily injection of 0.2 ml of normal saline during 30 days.
Treatment - Drugs
Study group: Daily injection of 40 mg of low-molecular weight heparin during 30 days
Control group: Daily injection of 0.2 ml of normal saline during 30 days

Sponsors

Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1- Recent chronic neuropathic diabetic foot ulcer (less than 10 days) 2- Ulcer Wagner grade is 1 or debrided patients or limited amputation with Wagner grade of 2, 3, and 4 3- ABI > 0.9 (not ischemic and neuroischemic) 4- Open or debrided ulcer or limited amputation 5- Having informed consent for study inclusion Exclusion Criteria 1- Chronic diabetic foot ulcers caused by ischemia 2- Under treatment with anticoagulant therapy at the time of study inclusion 3- contraindication of low molecular weight heparin administration, including severe renal failure (creatinine lower than 30 ml/min (hepatic failure of Child-Pugh class B or C, having bleeding disorders and proliferative diabetic retinopathy subject to bleeding risk 4- Active osteomyelitis 5- Systemic sepsis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Diabetic Foot Ulcer. Timepoint: every 10 days in 30-day period. Method of measurement: Digital imaging.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Milad Sarrafi

Guilan University of Medical Sciences

Miladsarafi@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026